is glp-1 safe if you don't have diabetes medications were first developed to treat type 2 diabetes, not obesity., Appetite suppression the effect patients feel. But insulin regulation, glucagon suppression, and gastric slowing are How Do You Know When

These new medications increase satiety, meaning the feeling of fullness or satisfaction after a meal

CDC [Internet]

Shayla Dunlap, FNP, explains the four key options: Ozempic and Mounjaro (originally for type 2 diabetes), Wegovy and Zepbound (designed for weight loss), and compounded medications like semaglutide and tirzepatide

"Look at the results objectively at every stage: If you're gaining weight back, it's an indication your body needs the higher dose," she says

10.3389/fphar.2020.600175 Summary Keywords anti-inflammatory effects, clinical applications, GLP-1RAs, liver injury, metabolic regulation Citation Hu Z, Tian D, Yang Z, Zhang J, Zhang L, Xu Y and Lu X (2026) The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation

They do not replace insulin Ozempic and Mounjaro do not replace insulin